Evidence map›Paper›PMID 33173241›Full record

ArticleGeburtshilfe und Frauenheilkunde2020

Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine.

Elena Laakmann, Julius Emons, Florin-Andrei Taran, Wolfgang Janni, Sabrina Uhrig, Friedrich Overkamp, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle and 20 more

Erratum issuedOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Geburtshilfe und Frauenheilkunde, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 19 institutions in 2 countries.

Elena LaakmannDepartment of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.
Julius EmonsErlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Florin-Andrei TaranDepartment of Gynecology, Zurich University Hospital, Zurich, Switzerland.
Wolfgang JanniDepartment of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
Sabrina UhrigErlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Friedrich OverkampOncologianova GmbH, Recklinghausen, Germany.
Hans-Christian KolbergDepartment of Marienhospital Bottrop, Bottrop, Germany.
Peyman HadjiFrankfurt Center of Bone Health Frankfurt, Frankfurt, Germany.
Hans TeschOncology Practice at Bethanien Hospital Frankfurt, Frankfurt, Germany.
Lothar HäberleErlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Johannes EttlDepartment of Obstetrics and Gynecology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Diana LüftnerCharité University Hospital, Berlin, Department of Hematology, Oncology and Tumour Immunology, Berlin, Germany.
Markus WallwienerDepartment of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
Carla SchulmeyerErlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Volkmar MüllerDepartment of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.
Matthias W BeckmannErlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Erik BellevilleClinSol GmbH & Co. KG, Würzburg, Germany.
Pauline WimbergerNational Center for Tumor Diseases (NCT), Dresden, Germany.
Carsten Hielscherg.SUND Center for Gynecologic Oncology Stralsund, Stralsund, Germany.
Christian KurbacherDepartment of Gynecology I (Gynecologic Oncology), Gynecologic Center Bonn-Friedensplatz, Bonn, Germany.
Rachel WuerstleinDepartment of Gynecology and Obstetrics, Breast Center and CCC Munich, University Hospital Munich LMU, Munich, Germany.
Christoph ThomssenDepartment of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Michael UntchDepartment of Gynecology and Obstetrics, Helios Clinics Berlin Buch, Berlin, Germany.
Bernhard VolzAnsbach University of Applied Sciences, Ansbach, Germany.
Peter A FaschingErlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Tanja N FehmDepartment of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany.
Diethelm WallwienerDepartment of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.
Sara Y BruckerDepartment of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.
Andreas SchneeweissNational Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Andreas D HartkopfDepartment of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.
Comprehensive Cancer Center Erlangen · DEUniversity of Tübingen · DEHeidelberg University · DEUniversity Medical Center Hamburg-Eppendorf · DEAnsbach University of Applied Sciences · DEBrüderkrankenhaus St. Josef Paderborn · DECardiovascular Center Bethanien · DECardiovascular Center Frankfurt · DECharité - Universitätsmedizin Berlin · DEHeinrich Heine University Düsseldorf · DEHelios Hospital Berlin-Buch · DEHelmholtz-Zentrum Dresden-Rossendorf · DELMU Klinikum · DEMarienhospital Bottrop · DEMartin Luther University Halle-Wittenberg · DETechnical University of Munich · DEUniversity Hospital of Zurich · CHUniversity Hospital Ulm · DEUniversity of Applied Sciences Stralsund · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

advanced breast cancerantihormone therapychemotherapyHER2 c-erbB2HER2/neulapatinibmetastaticpertuzumabT-DM1trastuzumab

Identifiers

PMID33173241
PMCPMC7647719
OpenAlexW3095699403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.